UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2004
OR
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 001-05519
CDI CORP.
| Pennsylvania | 23-2394430 | |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
1717 Arch Street, 35th Floor, Philadelphia, PA 19103-2768
Registrants telephone number, including area code:
|
(215) 569-2200 | |
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes þ No o
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Section 12b-2 of the Exchange Act.)
Yes þ No o
Outstanding shares of each of the Registrants classes of common stock as of July 26, 2004 were:
Common stock, $.10 par value
|
19,699,105 shares | |
Class B common stock, $.10 par value
|
None |
CDI CORP.
Table of Contents
PART 1. FINANCIAL INFORMATION
| June 30, | December 31, | |||||||
| 2004 | 2003 | |||||||
| (unaudited) |
|
|||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 49,195 | 50,230 | |||||
Accounts receivable, less allowance for
doubtful accounts of $5,025 - June
30, 2004; $5,496- December 31, 2003 |
203,600 | 199,630 | ||||||
Short-term investments |
29,857 | 22,606 | ||||||
Prepaid expenses |
9,873 | 8,744 | ||||||
Deferred income taxes |
7,186 | 8,484 | ||||||
Total current assets |
299,711 | 289,694 | ||||||
Property and equipment, at cost: |
||||||||
Computers and systems |
87,863 | 85,426 | ||||||
Equipment and furniture |
26,639 | 26,256 | ||||||
Leasehold improvements |
13,566 | 13,297 | ||||||
| 128,068 | 124,979 | |||||||
Accumulated depreciation |
(98,654 | ) | (93,858 | ) | ||||
Property and equipment, net |
29,414 | 31,121 | ||||||
Deferred income taxes |
6,418 | 7,133 | ||||||
Goodwill, net |
68,211 | 68,211 | ||||||
Other assets |
3,908 | 5,403 | ||||||
Total assets |
$ | 407,662 | 401,562 | |||||
See accompanying notes to consolidated financial statements.
1
CDI CORP. AND SUBSIDIARIES
Consolidated Balance Sheets
(In thousands, except share data)
| June 30, | December 31, | |||||||
| 2004 | 2003 | |||||||
| (unaudited) |
|
|||||||
Liabilities and Shareholders Equity |
||||||||
Current liabilities: |
||||||||
Obligations not liquidated because of
outstanding checks |
$ | 3,561 | 5,848 | |||||
Accounts payable |
20,484 | 23,824 | ||||||
Withheld payroll taxes |
4,435 | 2,596 | ||||||
Accrued compensation and related expenses |
50,187 | 44,343 | ||||||
Other accrued expenses |
12,656 | 18,191 | ||||||
Income taxes payable |
1,217 | 464 | ||||||
Total current liabilities |
92,540 | 95,266 | ||||||
Deferred compensation |
7,606 | 8,945 | ||||||
Total liabilities |
100,146 | 104,211 | ||||||
Shareholders equity: |
||||||||
Preferred stock, $.10 par value -
authorized 1,000,000 shares; none issued |
| | ||||||
Common stock, $.10 par value -
authorized 100,000,000 shares; issued
20,661,499 shares June 30, 2004;
20,535,835 shares December 31, 2003 |
2,066 | 2,054 | ||||||
Class B common stock, $.10 par value -
authorized 3,174,891 shares; none issued |
| | ||||||
Additional paid-in capital |
31,501 | 28,205 | ||||||
Retained earnings |
293,079 | 286,466 | ||||||
Accumulated other comprehensive income |
3,588 | 3,467 | ||||||
Unamortized value of restricted stock issued |
(408 | ) | (544 | ) | ||||
Less common stock in treasury, at cost -
963,934 shares June 30, 2004;
963,465 shares December 31, 2003 |
(22,310 | ) | (22,297 | ) | ||||
Total shareholders equity |
307,516 | 297,351 | ||||||
Total liabilities and shareholders equity |
$ | 407,662 | 401,562 | |||||
See accompanying notes to consolidated financial statements.
2
CDI CORP. AND SUBSIDIARIES
| Three months ended | Six months ended | |||||||||||||||
| June 30, |
June 30, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Revenues |
$ | 264,839 | 269,994 | 520,826 | 539,520 | |||||||||||
Cost of services |
201,806 | 204,824 | 396,545 | 405,974 | ||||||||||||
Gross profit |
63,033 | 65,170 | 124,281 | 133,546 | ||||||||||||
Operating and administrative expenses |
56,781 | 56,452 | 110,633 | 116,466 | ||||||||||||
Gain on sale of assets |
(1,295 | ) | | (1,295 | ) | | ||||||||||
Operating profit |
7,547 | 8,718 | 14,943 | 17,080 | ||||||||||||
Interest income, net and other |
136 | 252 | 404 | 626 | ||||||||||||
Earnings before income taxes |
7,683 | 8,970 | 15,347 | 17,706 | ||||||||||||
Income tax expense |
2,474 | 2,867 | 5,202 | 6,143 | ||||||||||||
Net earnings |
$ | 5,209 | 6,103 | 10,145 | 11,563 | |||||||||||
Basic earnings per share |
$ | 0.27 | 0.32 | 0.52 | 0.60 | |||||||||||
Diluted earning per share |
$ | 0.26 | 0.31 | 0.51 | 0.59 | |||||||||||
See accompanying notes to consolidated financial statements.
3
CDI CORP. AND SUBSIDIARIES
| Three months ended | Six months ended | |||||||||||||||
| June 30, |
June 30, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Common stock |
||||||||||||||||
Beginning of period |
$ | 2,058 | 2,034 | 2,054 | 2,031 | |||||||||||
Exercise of stock options |
7 | 3 | 10 | 4 | ||||||||||||
Stock purchase plans |
1 | 2 | 2 | 4 | ||||||||||||
End of period |
$ | 2,066 | 2,039 | 2,066 | 2,039 | |||||||||||
Additional paid-in capital |
||||||||||||||||
Beginning of period |
$ | 29,157 | 23,424 | 28,205 | 22,975 | |||||||||||
Exercise of stock options |
1,833 | 579 | 2,542 | 703 | ||||||||||||
Restricted stock change in value |
1 | (1 | ) | (1 | ) | (3 | ) | |||||||||
Stock purchase plans |
250 | 418 | 335 | 733 | ||||||||||||
Tax benefit from stock plans |
260 | 99 | 420 | 111 | ||||||||||||
End of period |
$ | 31,501 | 24,519 | 31,501 | 24,519 | |||||||||||
Retained earnings |
||||||||||||||||
Beginning of period |
$ | 289,637 | 311,799 | 286,466 | 306,339 | |||||||||||
Net earnings |
5,209 | 6,103 | 10,145 | 11,563 | ||||||||||||
Dividends paid to shareholders |
(1,767 | ) | | (3,532 | ) | | ||||||||||
End of period |
$ | 293,079 | 317,902 | 293,079 | 317,902 | |||||||||||
Accumulated other comprehensive income (loss) |
||||||||||||||||
Beginning of period |
$ | 4,097 | (810 | ) | 3,467 | (610 | ) | |||||||||
Foreign currency translation adjustment |
(446 | ) | 2,356 | 184 | 2,156 | |||||||||||
Unrealized loss on investments |
(63 | ) | | (63 | ) | | ||||||||||
End of period |
$ | 3,588 | 1,546 | 3,588 | 1,546 | |||||||||||
Unamortized value of restricted stock issued |
||||||||||||||||
Beginning of period |
$ | (474 | ) | (737 | ) | (544 | ) | (800 | ) | |||||||
Restricted stock vesting/forfeiture |
| | 13 | | ||||||||||||
Restricted stock change in value |
(1 | ) | 1 | 1 | 3 | |||||||||||
Restricted stock amortization of value |
67 | 68 | 122 | 129 | ||||||||||||
End of period |
$ | (408 | ) | (668 | ) | (408 | ) | (668 | ) | |||||||
Treasury stock |
||||||||||||||||
Beginning of period |
$ | (22,310 | ) | (22,134 | ) | (22,297 | ) | (22,134 | ) | |||||||
Restricted stock forfeiture |
| | (13 | ) | | |||||||||||
End of period |
$ | (22,310 | ) | (22,134 | ) | (22,310 | ) | (22,134 | ) | |||||||
Comprehensive income |
||||||||||||||||
Net earnings |
$ | 5,209 | 6,103 | 10,145 | 11,563 | |||||||||||
Foreign currency translation adjustment |
(446 | ) | 2,356 | 184 | 2,156 | |||||||||||
Unrealized loss on investment |
(63 | ) | | (63 | ) | | ||||||||||
End of period |
$ | 4,700 | 8,459 | 10,266 | 13,719 | |||||||||||
See accompanying notes to consolidated financial statements.
4
CDI CORP. AND SUBSIDIARIES
| Six months ended | ||||||||
| June 30, |
||||||||
| 2004 |
2003 |
|||||||
Operating activities: |
||||||||
Net earnings |
$ | 10,145 | 11,563 | |||||
Adjustments to reconcile net earnings to cash provided by operating activities: |
||||||||
Depreciation |
4,839 | 6,893 | ||||||
Deferred income tax expense |
2,013 | 5,107 | ||||||
Gain on sale of assets |
(1,295 | ) | | |||||
Tax benefit from stock plans |
420 | 111 | ||||||
Change in assets and liabilities, net of effects of divestitures: |
||||||||
Accounts receivable, net |
(3,951 | ) | (13,280 | ) | ||||
Prepaid expenses |
(3,151 | ) | (2,575 | ) | ||||
Accounts payable |
(3,334 | ) | (3,489 | ) | ||||
Accrued expenses other current liabilities |
4,072 | (3,552 | ) | |||||
Other assets, long-term liabilities and other |
552 | 1,057 | ||||||
Net cash flow provided by operating activities |
10,310 | 1,835 | ||||||
Investing activities: |
||||||||
Purchases of property and equipment |
(3,106 | ) | (7,786 | ) | ||||
Purchases of short-term investments |
(7,251 | ) | (287 | ) | ||||
Proceeds from sale of assets |
2,162 | | ||||||
Proceeds from notes receivable |
| 3,050 | ||||||
Other |
(24 | ) | 475 | |||||
Net cash flow used in investing activities |
(8,219 | ) | (4,548 | ) | ||||
Financing activities: |
||||||||
Dividends paid to shareholders |
(3,532 | ) | | |||||
Obligations not liquidated because of outstanding checks |
(2,287 | ) | 7,434 | |||||
Proceeds from exercises of employee stock options |
2,552 | 707 | ||||||
Net cash flow (used in) provided by financing activities |
(3,267 | ) | 8,141 | |||||
Effect of exchange rate changes on cash |
141 | 38 | ||||||
Net (decrease) increase in cash and cash equivalents |
(1,035 | ) | 5,466 | |||||
Cash and cash equivalents, beginning of period |
50,230 | 41,148 | ||||||
Cash and cash equivalents, end of period |
$ | 49,195 | 46,614 | |||||
Supplemental disclosure of cash flow information: |
||||||||
Cash paid during the period for income taxes, (net of refunds) |
$ | 1,346 | (3,887 | ) | ||||
See accompanying notes to consolidated financial statements.
5
CDI Corp.
| 1. | Basis of Presentation |
The accompanying consolidated financial statements of CDI Corp. (CDI or the Company) are unaudited. The balance sheet as of December 31, 2003 is derived from the audited balance sheet of the Company at that date. These statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission pertaining to reports on Form 10-Q and should be read in conjunction with the Companys consolidated financial statements and the notes thereto for the year ended December 31, 2003 reported in Form 10-K, filed March 12, 2004. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations.
The consolidated financial statements for the unaudited interim periods presented include all adjustments (consisting of only normal, recurring adjustments) necessary for a fair presentation of financial position, results of operations and cash flows for such interim periods. Certain amounts in prior periods have been reclassified to conform to the current period classification. In that regard, cash flow from operations, investing activities and financing activities for the six months ended June 30, 2003 were revised by $2.4 million, $3.1 million and $0.7 million, respectively, principally to reflect proceeds from a note receivable.
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and disclosure of contingent assets and liabilities. Actual results could differ from those estimates. Results for the three and six month periods ended June 30, 2004 are not necessarily indicative of results that may be expected for the full year or any portion thereof.
| 2. | Cash, Cash Equivalents and Short-Term Investments |
Cash, cash equivalents and short-term investments as of June 30, 2004 and December 31, 2003 were comprised of the following:
| June 30, | December 31, | |||||||
| 2004 |
2003 |
|||||||
Cash |
$ | 5,967 | 5,139 | |||||
Cash equivalents |
43,228 | 45,091 | ||||||
Total cash and cash equivalents |
49,195 | 50,230 | ||||||
Short-term investments |
29,857 | 22,606 | ||||||
Total cash, cash equivalents and
short-term investments |
$ | 79,052 | 72,836 | |||||
Cash equivalents and short-term investments are in liquid, high quality debt securities with diversification among the investments based upon the Companys guidelines. Amortized cost approximates fair value. Gains and losses during the three and six month periods ended June 30, 2004 were immaterial.
All of the Companys short-term investments are held as available-for-sale securities, and reflect investments in corporate bonds, various government agencies and commercial paper. Available-for-sale securities as of June 30, 2004 of $29.9 million include $25.6 million for securities maturing in one year or less and $4.3 million for securities maturing in one to three years.
6
| 3. | Restructuring |
There were no restructuring charges during the first six months of 2004 and 2003.
The table presented below shows the current year activity related to previous restructurings from a balance sheet perspective:
| Net Accrual at | Net Accrual at | |||||||||||
| December 31, | June 30, | |||||||||||
| 2003 |
Payments |
2004 |
||||||||||
Severance |
$ | 633 | (573 | ) | 60 | |||||||
Lease obligations |
2,934 | (1,631 | ) | 1,303 | ||||||||
| $ | 3,567 | (2,204 | ) | 1,363 | ||||||||
The remaining liability for severance will be substantially paid during the balance of 2004. The Company anticipates that the remaining liability for the termination of operating leases will be substantially paid by December 31, 2005. The accrual for restructuring charges is included in other accrued expenses in the accompanying consolidated balance sheets.
| 4. | Real Estate Exiting Costs |
During the first half of 2004, the Company experienced continued declines in demand in its Life Sciences vertical within the Business Solutions segment. As a result, in the second quarter of 2004, management reorganized certain office space and determined that there was excess real estate capacity within the Life Sciences vertical. In addition, management also determined that there was excess real estate capacity in the MRI segment. Accordingly, certain real estate properties were permanently vacated resulting in the Company recording a pre-tax charge of approximately $1.0 million in the second quarter of 2004. This charge is included in operating and administrative expenses in the accompanying consolidated statements of earnings.
The table presented below shows the current year activity by reportable segments:
| Net Accrual | ||||||||||||
| Business | at June 30, | |||||||||||
| Solutions |
MRI |
2004 |
||||||||||
Balance as of December 31, 2003 |
$ | | | | ||||||||
Charge for real estate exiting costs |
834 | 164 | 998 | |||||||||
Payments |
| (53 | ) | (53 | ) | |||||||
Balance as of June 30, 2004 |
$ | 834 | 111 | 945 | ||||||||
The future payments related to the above lease obligations are expected to extend through 2006. The accrual for vacant lease obligations is included in other accrued expenses in the accompanying consolidated balance sheets.
| 5. | Earnings Per Share |
Both basic and diluted earnings per share for all periods are calculated based on the reported earnings in the Companys consolidated statements of earnings.
The number of common shares used to calculate basic and diluted earnings per share for three and six months ended June 30, 2004 and 2003 was determined as follows:
7
| Three months ended | Six months ended | |||||||||||||||
| June 30, |
June 30, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Basic |
||||||||||||||||
Average shares outstanding |
19,648,123 | 19,400,900 | 19,619,615 | 19,383,796 | ||||||||||||
Restricted shares issued not vested |
(30,900 | ) | (45,000 | ) | (31,088 | ) | (45,187 | ) | ||||||||
| 19,617,223 | 19,355,900 | 19,588,527 | 19,338,609 | |||||||||||||
Diluted |
||||||||||||||||
Shares used for basic calculation |
19,617,223 | 19,355,900 | 19,588,527 | 19,338,609 | ||||||||||||
Dilutive effect of stock options |
369,650 | 257,673 | 320,143 | 183,680 | ||||||||||||
Dilutive effect of restricted shares
issued not vested time based |
12,136 | 12,690 | 10,171 | 9,474 | ||||||||||||
Dilutive effect of restricted shares issued
not vested performance based |
250 | 250 | 188 | 188 | ||||||||||||
Dilutive effect of units issuable under
stock purchase plans |
100,091 | 112,752 | 99,128 | 114,800 | ||||||||||||
| 20,099,350 | 19,739,265 | 20,018,157 | 19,646,751 | |||||||||||||
| 6. | Stock Based Plans |
The Company uses the intrinsic value method of accounting for stock options and other forms of stock-based compensation granted to employees and directors, in accordance with Accounting Principles Board Opinion No. 25 (APB 25), Accounting for Stock Issued to Employees. No compensation cost has been recognized for grants of stock options because option exercise prices are not less than the fair market value of the underlying common stock at dates of grant. Compensation cost has been recognized for restricted stock issued and for units granted under the Stock Purchase Plan and Stock Unit Plan.
SFAS No. 123, Accounting for Stock Based Compensation, uses a fair value based method of accounting for stock-based compensation. The following table reflects the pro-forma effect on net earnings and earnings per share for the three and six month periods ended June 30, 2004 and 2